INTRODUCTION {#SEC1}
============

The human gut microbiota represents an extremely complex microbial assembly of an estimated 10--100 trillion symbiotic bacteria per individual ([@B1]). Common representatives of this microbiota include members of the genus *Bifidobacterium*, which are particularly prevalent in the gastrointestinal tract (GIT) of healthy, breast-fed infants, where they are among the first colonizers of the newborn gut ([@B2]). Low abundance of bifidobacteria has been associated with a number of diseases, e.g. inflammatory bowel disease, metabolic syndrome, and colorectal cancer, thereby presenting possibilities for their use as biomarkers or treatments ([@B3]). Members of this genus have therefore been incorporated as live ingredients of functional foods, while they have also enjoyed intense scientific scrutiny, including comparative and functional genomic efforts aimed at unraveling the molecular mechanisms underlying their beneficial activity.

*Bifidobacterium breve* (next to *B. longum* and *B. bifidum*) is abundantly present in the gut microbiota of healthy infants ([@B2],[@B6]), and has been subject of genetic studies, including insertional mutagenesis ([@B11]). *In silico* comparative and pan-genome analysis of 25 *B. breve* genomes revealed that ∼70% of the gene content of a given strain is common to all members of this species (designated the core genome), while the remaining genes (i.e. the variome) represent intra-species diversity ([@B14]).

Genes encoding Restriction/Modification (R/M) and CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic Repeats) systems are part of the *B. breve* variome, and represent defense systems against invasion by exogenous DNA ([@B14]). R/M systems are relevant for the study of bifidobacteria as they obstruct genetic accessibility ([@B18]). In bifidobacteria three types of base modification are predicted: N6-methyladenine (m6A), N4-methylcytosine (m4C) and 5-methylcytosine (m5C) ([@B21]), which can be detected using a combination of PacBio SMRT and Illumina bisulfite sequencing (BS-seq) ([@B22],[@B23]). Methyltransferases (MTases) are typically found as part of R/M systems, which use base methylation to discriminate 'self' from 'non-self' DNA, protecting methylated host DNA from cleavage while targeting unmethylated exogenous DNA ([@B16],[@B24]). Individual R/M systems are generally composed of one or more MTases and restriction endonucleases (REases), and are classified into four Types (I, II, III, IV) based on the number of subunits, co-factor requirements, mechanism of action, target sequence and type of cleavage ([@B24],[@B25]).

A typical Type I R/M system is multi-subunit complex, which is comprised of an REase (named HsdR or R) responsible for ATP-dependent DNA cleavage, an MTase (named HsdM or M) producing m6A or m4C methylated bases, and a specificity determinant (HsdS or S) responsible for recognition of (in most cases) asymmetric (rather than palindromic) sites. DNA cleavage by a Type I REase occurs at a variable distance from the recognition sequence ([@B25],[@B26]). Type II R/M systems typically consist of two distinct enzymes (MTase and REase) recognizing palindromic sequences, within which the REase introduces a symmetrical double-stranded cut. The Type II family represents the most heterogeneous group of R/Ms in bacteria, further divided in 11 subtypes (IIA, IIB, IIC, IIE, IIF, IIG, IIH, IIM, IIP, IIS and IIT), based on the genetic arrangement of its constituent REase and MTase components, and the target or type of cleavage ([@B25]).

To date \>200 bifidobacterial R/Ms have been predicted (<http://rebase.neb.com/cgi-bin/pacbiolist>; <http://tools.neb.com/genomes>) ([@B21]). For only a few of these systems the recognition sequence of the REase has been determined by classical methods involving restriction analysis ([@B19],[@B27]), while in recent years their characterization has been assisted by Pacbio SMRT technology ([@B18],[@B20]). Methylase activity of three R/M systems has been described for *B. breve* UCC2003 (BbrUI, BbrUII and BbrUIII), where M.BbrUI and M.BbrUIII possess cytosine-specific MTase activity, while M.BbrUII is responsible for N6-adenosine methylation ([@B19]). Improvement in transformation efficiencies of bifidobacterial strains have been shown to be achievable using plasmid modification which would elude cleavage by the host-encoded R-M systems ([@B31]). This approach applied to *B. breve* UCC2003 showed that transformation efficiency can be increased by more than 1000-fold when the endogenous R/M systems are by-passed by the use of pre-methylated plasmid DNA, obtained from an *E. coli* strain expressing the M.BbrUII and M.BbrUIII MTases ([@B19]).

The current work reports on the sequencing of a large *B. breve* collection employing PacBio SMRT sequencing, generating an updated view on strain diversity of this species. Furthermore, SMRT-mediated methylome analysis, combined with Illumina BS-seq and comparative genome analysis, allowed us to determine the methylome of this species, thereby providing an overview of the harbored R/M systems with corresponding recognition sites. Therefore, the information generated will constitute a solid reference for future improvement of genetic accessibility of members of this species.

MATERIALS AND METHODS {#SEC2}
=====================

DNA isolation and CGH experiments {#SEC2-1}
---------------------------------

Bifidobacterial strains used in this study ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}) were routinely cultivated at 37°C in an anaerobic chamber (Davidson and Hardy, Belfast, Ireland) in Reinforced Clostridial Medium (RCM Oxoid, Ltd., Basingstoke, Hampshire, United Kingdom). Where appropriate, tetracycline (Tc; 10 μg ml^−1^), chloramphenicol (Cm; 3 μg ml^−1^), erythromycin (Em; 1 μg ml^−1^) or spectinomycin (Sp; 100 μg ml^−1^) was included in the growth medium. Following growth, total bifidobacterial DNA was isolated as previously described ([@B32]) and then labelled using the Kreatech ULS labelling kit according to the manufacturer\'s instructions (Kreatech, Amsterdam, The Netherlands). Labelled total gDNA was hybridized as described in the Agilent manual 'Two-Color Microarray-Based Gene Expression Analysis' (v4.0) (publication no. G4140--90050) to the *B. breve* UCC2003 microarray slides (feature format: 4 × 44K) overnight at 65°C (NB. *B. breve* UCC2003 was used as the reference strain and as a positive control). Following hybridization, microarrays were washed in accordance with Agilent standard procedures and scanned using an Agilent DNA microarray scanner (model G2565A). Generated scans were converted to data files with Agilent Feature Extraction software (Version 9.5). DNA microarray data sets were processed as previously described ([@B33]). Differential signal intensity tests were performed with the Cyber-T implementation of a variant of the *t*-test ([@B36]). Data were analysed and visualized using the Multi-experiment Viewer Tmev v.4.9 with hierarchical clustering analysis based on covariance method and complete linkage.

SMRT sequencing and sequence annotation {#SEC2-2}
---------------------------------------

Genome sequencing of *B. breve* strains was performed by GATC Biotech Ltd. (Germany) using Pacific Biosciences SMRT RSII technology. Raw sequencing reads were *de novo* assembled using the Hierarchical Genome Assembly Process (HGAP) protocol RS_Assembly.2 implemented in the SMRT Analysis software v.2.3 with default parameters (<https://github.com/PacificBiosciences/SMRT-Analysis>).

Open Reading Frame (ORF) prediction and automatic annotation was performed using Prodigal v2.0 (<http://prodigal.ornl.gov>) for gene predictions, BLASTP v2.2.26 (cut-off *E-*value of 0.0001) ([@B37]) for sequence alignments against a combined bifidobacterial genome-based database, and MySQL relational database to assign annotations. Predicted functional assignments were manually revised and edited using similarity searches against the non-redundant protein database curated by the National Centre for Biotechnology Information (<ftp://ftp.ncbi.nih.gov/blast/db/>) and PFAM database (<http://pfam.sanger.ac.uk>), which allowed a more detailed, *in silico* characterization of hypothetical proteins. GenBank editing and manual inspection was performed using Artemis v18 (<http://www.sanger.ac.uk/resources/soft-ware/artemis/>). Transfer RNA genes were identified employing tRNAscan-SE v1.4 and ribosomal RNA genes were detected based on the software package Rnammer v1.2 ([@B38]) supported by BLASTN v2.2.26.

Comparative genomics {#SEC2-3}
--------------------

Genomic synteny among individual *B. breve* genomes was inspected using whole-genome DNA sequence alignments using the software package MUMmer v3.0 ([@B39]). Comparisons and alignments at protein and nucleotide levels were performed on sequences deduced using the same ORF prediction pipeline Prodigal v2.0 (<http://prodigal.ornl.gov>). Comparative genome analyses were performed using a combination of all-against-all, bi-directional BLAST alignments ([@B37]) (cut-off: *E*-value \< 0.0001, with at least 50% identity across at least 50% of either protein sequence), and the Markov Cluster Algorithm (MCL) implemented in the mclblastline pipeline v12-0678 ([@B40]) in order to group corresponding genes into families that share a particular function. As part of the comparative genome analysis all identified gene families were assigned to either the core genome or to the dispensable genome based on their presence in all analysed strains or in a subset, respectively.

Phylogenomic analyses {#SEC2-4}
---------------------

Phylogenomic relationships between strains were assessed based on nucleotide alignments of the core genome gene content, which included only single-copy orthologues. An additional filter for paralogues was applied to the core genome in order to exclude families represented by more than a single member, as they do not represent robust evolutionary markers ([@B41]). Gene alignments were conducted using MUSCLE v.3.8.31 ([@B42]), followed by construction of a phylogenetic tree for each single-copy gene using the maximum-likelihood in PhyML v3.0 ([@B43]) and tree concatenation. A final consensus tree was computed using the Consense module from Phylip package v3.69 (<http://evolution.genetics.washington.edu/phylip.html>) using the majority rule method.

Methylome analysis (SMRT and BS-seq sequencing) {#SEC2-5}
-----------------------------------------------

Methylome analysis was performed using a combination of SMRT sequencing and comparative genome analysis. Base modification and methylated motif detection was performed employing the SMRT Analysis portal following *de novo* genome assembly using the 'RS_Modification_and_Motif_Analysis.1' protocol. Methylation motifs with a score of 40 (corresponding to a *P*-value of 0.0001) or higher were considered specific and were taken for further analysis (<https://github.com/PacificBiosciences/Bioinformatics-Training/wiki/Methylome-Analysis-Technical-Note>).

The deduced protein products of all identified ORFs were searched for similarity to known R/M systems (including orphan methylases) using BLASTP ([@B37]) alignments against the REBASE database (<http://rebase.neb.com/rebase/rebase.html>) ([@B21]). Significant BLASTP hits were selected using a cut-off *E*-value of \<0.0001 and exhibiting over 30% similarity across at least 80% of the sequence length. Further manual refinement of these predictions included discarding of false positive BLASTP hits and refinement using PFAM database (<http://pfam.sanger.ac.uk>). A comparative genome analysis was employed to associate the presence of R/M system-encoding genes with the presence of methylation motif(s).

In selected cases, Illumina sequencing of bisulfite-treated chromosomal DNA (termed BS-seq) was performed in order to reliably detect m5C-methylated bases. The strains subjected to BS-seq were *B. breve* NRBB01, *B. breve* NRBB02, *B. breve* NRBB11, *B. breve* NRBB56, *B. breve* NRBB50, *B. breve* DRBB26, *B. breve* DRBB28 and *B. breve* 215W4--47a. BS-seq was performed by GATC Biotech Ltd. (Germany) using a HiSeq 2500 platform employing a paired-end library and generating sequencing read lengths of 125 bp. The obtained BS-seq raw data sets were subjected to Bismark software (v.0.14.5) analysis in order to reveal the presence of m5C modifications and the identification of corresponding methylation (recognition) motifs. Raw reads were low-quality filtered using NGSQCToolkit_v2.3.3 (<http://www.nipgr.res.in/ngsqctoolkit.html>) and mapped on the finished reference genome using Bismark v0.14.5 developed by Babraham Bioinformatics (<http://www.bioinformatics.babraham.ac.uk/projects/bismark/>) in a non-directional mode. Methylated cytosines were extracted from a BedGraph output using 80% of m5C\>T conversion as a cut-off value and sequence context was analysed by extracting +/- 10 bp around each identified methylated position. Meme suite (<http://meme-suite.org/>) was employed to determine a context consensus at positions where methylations were observed and Integrative Genomics Viewer v2.3 (<https://www.broadinstitute.org/igv/>) was used for data visualization and inspection.

Plasmid DNA isolation and transformation of *B. breve* strains {#SEC2-6}
--------------------------------------------------------------

Mini-preparation of plasmid DNA from *E. coli* or *B. breve* (Table [1](#tbl1){ref-type="table"}) was performed using the Qiaprep spin plasmid miniprep kit (Qiagen GmBH, Hilden, Germany). For isolation of bifidobacterial DNA, an initial lysis step was incorporated into the plasmid isolation procedure, cells were resuspended in lysis buffer supplemented with lysozyme (30 mg ml^−1^) and incubated at 37°C for 30 min. For transformation of *B. breve* strains 50 ml of modified Rogosa medium mMRS prepared from first principles ([@B44]) supplemented with 0.05% cysteine, and 1% glucose, lactose or maltose, was inoculated with 4 ml of a *B. breve* overnight culture and incubated anaerobically at 37°C. Once an optical density (OD~600nm~) value between 0.6--0.8 was reached, bacterial cells were collected by centrifugation at 4500 rpm for 10 min at 4°C. The obtained cell pellet was washed twice with chilled sucrose citrate buffer (1 mM citrate \[pH 5.8\], 0.5 M sucrose), and then resuspended in 200 μl of ice-cold sucrose citrate buffer. Fifty μl of the cell suspension was used for each electro-transformation; cells and plasmid DNA were mixed and held on ice prior to applying an electrical pulse at 25 μF, 200 ohms and 2 kV. Following this, 1 ml of reinforced clostridial medium (RCM) (Oxoid, Hampshire, England) was added to the cell suspension, which was then incubated anaerobically for 2.5 h at 37°C. Serial dilutions were plated on reinforced clostridial agar (RCA) containing the appropriate antibiotic and plates were incubated anaerobically at 37°C for 48 h, after which the transformation frequency was calculated as the number of transformants obtained per μg of plasmid DNA.

###### Plasmids used in this study

  Plasmid       Relevant characteristics                                       Reference or Source
  ------------- -------------------------------------------------------------- ------------------------------------------------
  **pNZ8048**   Gene expression vector P~nisA~, Cm^r^                          De Ruyter *et al.* (1996)
  **pDM1**      pAM5 derivative containing spectinomycin resistance cassette   O'Connell Motherway and Watson *et al.* (2014)
  **pAM5**      pBC1-puC19-Tc                                                  Alvarez-Martín *et al.* (2007)

Methylase cloning {#SEC2-7}
-----------------

For construction of the methylase gene-harbouring plasmid pNZ-M.NRBB52, the predicted methyltransferase-encoding gene NRBB52_0014 including its presumed promoter region was amplified by PCR employing chromosomal DNA of *B. breve* NRBB52 as a template, and using Q5 DNA polymerase. To facilitate cloning XbaI/HindIII restriction sites were incorporated at the 5′ ends of the forward and reverse primers, respectively. The generated NRBB52_0014-encompassing amplicon was digested with XbaI and HindIII, and ligated to pNZ8048 restricted with the same enzymes. The resulting ligation mixture was introduced into *Escherichia coli* EC101 ([@B45]) by electrotransformation, after which transformants were selected based on chloramphenicol resistance. The plasmid content of a number of transformants was screened by restriction analysis and the integrity of positively identified clones was verified by sequencing prior to introduction into the methylase-negative *E. coli* strain ER2796 ([@B46]).

The effect of methylation of plasmid DNA on the transformation efficiency of *B. breve* NRBB52 was subsequently assessed by introduction of the shuttle vector pAM5 into *E. coli* ER2796 pNZ-M.NRBB52. The corresponding plasmid preparations were then used to determine how efficiently pAM5 isolated from *E. coli* ER2796 pNZ-M.NRBB52 could be introduced into *B. breve* NRBB52 by electrotransformation.

RESULTS AND DISCUSSION {#SEC3}
======================

General genome features and comparative genomics of *B. breve* {#SEC3-1}
--------------------------------------------------------------

In order to determine intra-species diversity of *B. breve*, a collection of 71 *B. breve* strains ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}) was assessed by Comparative Genome Hybridization (CGH) using micro arrays that were based on the annotated genes of the *B. breve* UCC2003 genome as a reference. As controls we included six bifidobacterial strains that did not belong to *B. breve* as verified by (partial) 16S rRNA gene sequencing ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). Raw data analysis of the CGH results allowed the construction of a gene presence/absence matrix, which was used to perform a two-way hierarchical clustering, resulting in the identification of 24 distinct *B. breve* genome groups (Figure [1](#F1){ref-type="fig"}). Based on this CGH-directed grouping, 27 strains were selected for PacBio SMRT sequencing in order to obtain full genome sequences and to capture a wide range of *B. breve* genomic diversity. Table [2](#tbl2){ref-type="table"} outlines the salient features of the obtained *B. breve* genomes, being in line with what was previously described for (a smaller number of) members of this species and bifidobacteria in general ([@B14],[@B47]).

![CGH and hierarchical clustering of bifidobacterial strains. Heatmap representing presence (black) or absence (yellow) of *B. breve* variable genes obtained by comparative genomics hybridization (CGH) analyses across 71 *B. breve* and 6 non-*B. breve* strains. Clusters obtained using a two-way hierarchical clustering analysis are highlighted with blue boxes and relative cluster numbers are indicated.](gkx1289fig1){#F1}

###### General genome features of the 27 newly sequenced *B. breve* representatives (clonal strains are indicated in \*)

  Genome                         Size (bp)   CGH GROUP   ANI % (*B. breve* UCC2003)   Contigs   Pacbio Coverage   ORFs number   rRNA loci   Selected for Comparative analysis   TUG   Mobile regions   CRISPR    Accession number
  ------------------------------ ----------- ----------- ---------------------------- --------- ----------------- ------------- ----------- ----------------------------------- ----- ---------------- --------- ------------------
  ***B. breve* NRBB56**          2425122     2           98.9                         1         179               1985          2           Yes                                 10    3                13 kb     CP021394
  ***B. breve* NRBB52**          2379672     6           98.6                         1         354               1989          3           Yes                                 9     3                11 kb     CP021393
  ***B. breve* DRBB28**          2462170     24          98.6                         1         391               2096          2           Yes                                 51    5                No        CP021553
  ***B. breve* NRBB57**          2510381     12          98.7                         1         206               2125          3           Yes                                 48    4                No        CP021389
  ***B. breve* DRBB27\***        2435083     7           98.2                         1         349               2079          2           Yes                                 167   4                No        CP021552
  ***B. breve* DRBB29\***        2435086     7           98.2                         1         362               2084          2           No                                  \-    4                No        CP023198
  ***B. breve* NRBB09**          2265557     10          98.5                         1         445               1881          3           Yes                                 38    3                11 kb     CP021387
  ***B. breve* NRBB11**          2377562     11          98.6                         1         397               1916          3           Yes                                 17    3                17 kb     CP021388
  ***B. breve* CNCM I-4321\***   2464852     8           98.4                         1         339               2082          2           Yes                                 18    5                No        CP021559
  ***B. breve* DRBB30\***        2471118     8           98.4                         1         434               2098          3           No                                  \-    5                No        CP023199
  ***B. breve* DRBB26**          2396387     15          98.6                         1         335               1978          3           Yes                                 16    2                No        CP021390
  ***B. breve* NRBB01**          2269404     17          98.6                         1         536               1902          2           Yes                                 26    2                No        CP021384
  ***B. breve* NRBB04**          2324647     18          98.7                         1         168               1874          3           Yes                                 15    1                11 kb     CP021386
  ***B. breve* 139W4--23**       2411276     22          98.8                         1         289               2013          3           Yes                                 45    3                No        CP021556
  ***B. breve* NRBB02\***        2289884     20          98.7                         1         85                1872          2           Yes                                 37    1                12.5 kb   CP021385
  ***B. breve* NRBB08\***        2289759     20          98.7                         1         91                1875          2           No                                  \-    1                12.5 kb   CP023192
  ***B. breve* NRBB18\***        2289686     20          98.7                         1         197               1874          2           No                                  \-    1                12.5 kb   CP023193
  ***B. breve* NRBB19\***        2289726     20          98.7                         1         112               1875          2           No                                  \-    1                12.5 kb   CP023194
  ***B. breve* NRBB20\***        2289892     20          98.7                         1         111               1875          2           No                                  \-    1                12.5 kb   CP023195
  ***B. breve* NRBB27\***        2289838     20          98.7                         1         147               1871          2           No                                  \-    1                12.5 kb   CP023196
  ***B. breve* NRBB49\***        2289791     20          98.7                         1         346               1869          2           No                                  \-    1                12.5 kb   CP023197
  ***B. breve* 215W4--47a**      2589602     9           98.7                         1         274               2219          3           Yes                                 37    3                No        CP021558
  ***B. breve* 082W4--8**        2286339     21          98.8                         1         121               1885          3           Yes                                 8     2                No        CP021555
  ***B. breve* 180W8--3**        2273173     23          98.6                         1         309               1891          3           Yes                                 15    2                No        CP021557
  ***B. breve* 017W4--39**       2301422     23          98.7                         1         287               1923          2           Yes                                 9     2                No        CP021554
  ***B. breve* NRBB50**          2409058     13          98.8                         1         125               2021          3           Yes                                 22    2                No        CP021391
  ***B. breve* NRBB51**          2402272     13          98.5                         1         471               1960          3           Yes                                 14    2                13 kb     CP021392

Full length alignment of the generated genome sequences with the reference genome of *B. breve* UCC2003 returned an average nucleotide identity of 98.7% across all strains (Table [2](#tbl2){ref-type="table"}), confirming their identity as members of the *B. breve* species. Dotplot alignments of each genome against that of *B. breve* UCC2003 revealed full length genome synteny with interruptions observed where (presumed) mobile genetic elements are located, in support of the notion that *B. breve* genomes appear more stable and do not (or very rarely) suffer from major chromosomal rearrangements ([@B14]) ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). This observation differs from the situation in the closely related species *B. longum*, where such chromosomal rearrangements occur more frequently, suggesting that conservation of genome synteny is not a shared feature among related taxa ([@B18]). As apparent from dotplot alignments between representatives of *B. longum* species, such large chromosomal rearrangements are possibly promoted by insertion elements, as they involve regions that are commonly flanked by transposase-encoding genes (families IS30, IS21, ISL3) ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}).

The performed CGH analysis indicated that 11 out of 27 strains (isolated from the same source) were closely related. In order to determine the degree of similarity among these strains at nucleotide level and to verify if the observed differences were genuine, whole genome sequencing and nucleotide sequence alignments were performed. As the obtained result showed that these strains are clonal derivatives, we deduced that the observed differences were caused by hybridization bias (Table [2](#tbl2){ref-type="table"}). For this reason only one representative per clonal strain group was selected for subsequent comparative purposes (NB. for the phylogenomic analysis we used all fully sequenced genomes, see below), reducing the dataset to 19 newly sequenced and distinct *B. breve* representatives (Table [2](#tbl2){ref-type="table"}).

Comparative analysis was performed using all-against-all BLASTP alignments followed by clustering of (protein-encoding) gene families. These comparisons included the 19 newly sequenced strains, plus six previously completely sequenced *B. breve* genomes ([@B14]) which had been included in the CGH analysis, for a total of 25 representatives of this species. This analysis returned a total number of 3082 gene families, 27% higher than the previously computed *B. breve* pan-genome ([@B14]), indicating that the inclusion of 25 additionally sequenced strains substantially increases the *B. breve* pangenome. We furthermore confirmed our previous observations ([@B14],[@B15]) that mobile genetic elements, CRISPR genes and R/M systems constitute a significant portion of the dispensable genome (i.e. gene functions not common to all members of the species).

Phylogenomics of *B. breve* {#SEC3-2}
---------------------------

A phylogenomic investigation based on nucleotide alignments of the core genome of individual strains allowed us to deduce the evolutionary relationships between strains (as 16S rRNA sequence-based phylogeny does not provide sufficient resolution at the intraspecies level) ([@B48]). Unlike CGH and comparative genome-derived clustering (which are based on the presence-absence of genes), phylogenomic analysis is based on sequence alignment of core genes and for this reason more suitable for an in depth investigation of phylogenetic relationships between closely related taxa. For this analysis we used a total of 1031 core genes that are present in single copy, including a number of housekeeping (and thus essential) functions such as genes encoding DnaA, DNA gyrase, chaperone proteins DnaJ, GroEL and GroES, as well as functions involved in central carbon metabolism (e.g. transaldolase and transketolase) and amino acid transport and biosynthesis. The resulting phylogenomic tree (Figure [2](#F2){ref-type="fig"}) was computed using the 27 *B. breve* strains sequenced as part of this study as well as seven publicly available and fully sequenced *B. breve* representatives, while furthermore including *B. longum* subsp. *longum* NCIMB 8809 as an outgroup. The resulting tree clusters the *B. breve* strains in 12 phylogenetic groups where they appear to distribute evenly across the tree (with the exception of the *B. breve* NRBB02 clonal group which includes 7 representatives). It is worth noting that no strict correlation exists between the HCL clustering results derived from CGH analysis (Figure [1](#F1){ref-type="fig"}) and the phylogenomic tree (Figure [2](#F2){ref-type="fig"}). However, this may have been expected because the latter is based on sequence alignment of concatenated core genes, while the former is based on presence-absence of variably distributed gene families, and thus will not contain information on the relatedness of strains at phylogenetic level. In this regard it is worth mentioning that phylogenetic inference based on a selected set of concatenated genes may suffer from a number of inaccuracies ([@B49]).

![Phylogenomics of *B. breve*. Phylogenetic supertree computed on concatenated single-copy core genes and showing the existing relationship between 35 sequenced *B. breve* species. *B. longum* subsp. longum NCMIB 8809 was used as the outgroup and online available strains are also indicated in purple. *B. breve* clonal strains determined by our analysis are indicated in orange.](gkx1289fig2){#F2}

Methylated bases and recognition motifs in *B. breve* {#SEC3-3}
-----------------------------------------------------

PacBio SMRT sequencing also generates information on DNA methylation, and this data was used, in combination with BS-seq of selected strains, to determine the diversity and occurrence of methylated motifs that are recognized by R/M systems. Analysis of the sequencing kinetics indicated the presence of m6A, m5C and, though at a lower frequency, m4C across the investigated strains. Extraction of the sequence context of these modifications allowed the identification of nine motifs assignable to Type I R/Ms and thirteen to Type II/IIG R/Ms (Figure [3](#F3){ref-type="fig"}; Table [3](#tbl3){ref-type="table"} and [Supplementary Table S2](#sup1){ref-type="supplementary-material"}), constituting a total of 22 unique methylated motifs in the assessed *B. breve* strain collection.

![The *B. breve* methylome. (**A**) Circos plot representing the occurrence of detected motifs and methylated positions in *B. breve*. Methylated motifs are ordered as in the figure legend on the right (from outer to inner circle) and grouped based on their assignment to Type I (green), Type II (red) and Type IIG (blue) R/M system.The motif occurrence in genomes is also indicated. (**B**) Heatmap representing presence/absence of detected motifs across 20 *B. breve* strains. Motifs are grouped based on their assignment to Type I, Type II and Type IIG R/M system and the type of modification (m6A, m4C and m5C) is also indicated.](gkx1289fig3){#F3}

###### *Bifidobacterium breve* RM-COGs locus tags with associated methylome

  ----------------------
  ![](gkx1289tbl3.jpg)
  ----------------------

Adenine modification was detectable with high accuracy by PacBio SMRT sequencing (a given motif was detected as being methylated in \>90% of the predicted positions in a genome) and m6A methylation was assigned to nine distinct Type II/IIG motifs. Of these, four were palindromic and thus methylated on both strands, while the remaining five do not constitute a perfect palindrome and are hemi-methylated (Figure [4](#F4){ref-type="fig"}). Interestingly, 5′-G^m6^**A**[T]{.ul}C-3′ represents the most abundant m6A modification across the investigated *B. breve* strains in terms of number of methylated sites, followed by 5′-GTRA^m6^**A**YG-3′ and 5′-GGRC^m6^**A**G-3′ (Figure [3](#F3){ref-type="fig"}, panel A). Regarding methylated consensus sequences that are commonly known to be associated to Type I R/Ms ([@B50]), our analysis identified nine motifs that were assigned to Type I R/Ms, where m6A modification is present in the top and bottom strand (Figure [3](#F3){ref-type="fig"}).

![*B. breve* R/M systems and corresponding methylation motifs. Locus maps showing the gene organization of each R/M system detected in *B. breve*. For each system the RM-COG number, assigned nomenclature, type of system (I, II or IIG) and type of modification (m6A, m5C or m4C) are indicated. Methylated motifs obtained by PacBio and BS-seq are also reported (blue for m6A, pink for m5C and yellow for m4C), with an indication of single-strand (\*) and double strand (\*\*) methylation.](gkx1289fig4){#F4}

Cytosine modification was detectable using PacBio SMRT sequencing only in the case of m4C, although with lower confidence compared to m6A (average motif detection rate of 52%), being an intrinsic feature of SMRT technology. However, this type of methylation seems to be rare in *B. breve*, being observed in just a single instance (5′-TG[G]{.ul}^m4^**C**CA-3′) (Figure [3](#F3){ref-type="fig"}, panel B) (Table [3](#tbl3){ref-type="table"}), and being assigned to a possible Type II alpha R/M encoded within a mobile genetic region (see below). Finally, m5C modifications were detected by BS-seq in eight strains that had been selected based on the presence of REBASE-predicted cytosine (or unknown orphan) methylases, confirming the presence of this methylation type in three cases (Figure [3](#F3){ref-type="fig"}, panel B). Of these motifs, 5′-RT^m5^**C**[G]{.ul}AY-3′ seems to be the most abundant motif in *B. breve* in terms of the number of methylated sites, followed by 5′-C^m5^**C**W[G]{.ul}G-3′ and 5′-GG^m5^**C**[G]{.ul}CC-3′ (Figure [3](#F3){ref-type="fig"}, panel A).

Matching methyltransferases to their cognate motif {#SEC3-4}
--------------------------------------------------

To establish associations between predicted MTases and identified methylation motifs, an initial search for R/M systems across all 19 *B. breve* genomes was performed using the publicly available database (<ftp://ftp.neb.com/pub/rebase>) ([@B21]) and BLASTP alignments ([@B37]). All genes identified with this approach were organized into R/M systems when a predicted MTase-encoding gene was found in close proximity to a putative REase-specifying gene (or *vice versa*), or if both activities were predicted to be encoded by a single gene. In the case of genes encoding a predicted MTase or REase (with associated domains) without a closely positioned cognate partner, they were considered as orphan, possibly representing truncated, incomplete or non-functional systems ([@B51]).

Combining the SMRT/BS-seq-assisted methylome identification outputs (detecting methylated bases and the sequence context of occurrence) with comparative genomics (generating information on the presence or absence of R/M-encoding genes among strains) we were able to link the presence of specific methylated motifs with the presence of particular (predicted) R/M systems in corresponding *B. breve* strains ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}). Comparative analysis assisted by MCL-clustering allowed us to group the identified R/M system genes into clusters of orthology (here designated as RM-COGs), reflecting the presence of homologous systems across strains. Our analysis associated 15 distinct RM-COGs with 22 methylated motifs showing a certain degree of overlap across strains (Tables [3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}). Furthermore, for each of the identified R/M systems we were able to assign a corresponding recognition sequence from the pool of detected methylated motifs (Table [4](#tbl4){ref-type="table"}). Of these 22 motifs, nine were assigned to Type I with unique specificities for each strain. Type I systems belonging to the RM1-COGs are present in *B. breve* NRBB01 and *B. breve* CNCM I-4321, while those belonging to RM2-COGs are present in seven *B. breve* strains (Figure [5](#F5){ref-type="fig"}; Tables [3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}).

![Diversity of Type I R/M systems in *B. breve*. (**A**) Locus map showing gene organization and comparison between all identified Type I R/M systems found in *B. breve*. Genes are indicated as arrows and are coloured based on their predicted function. Percentage of similarity in BLASTP alignment across homologous genes is indicated. (**B**) Phylogenetic tree obtained following the alignment of the concatenated M and R-encoding genes of Type I R/M systems detected in *B. breve*. The resulting Neighbour Joining tree shows the clustering of Type I R/M systems in two main phylogenetic groups (red boxes).](gkx1289fig5){#F5}

###### *Bifidobacterium breve* MTases with assigned recognition sequence in REBASE

  ----------------------
  ![](gkx1289tbl4.jpg)
  ----------------------

The remaining 13 motifs were predicted to correspond to: (i) five Type II R/M systems responsible for m6A modification, (ii) one Type II R/M system possibly responsible for m4C modification, (iii) three Type II R/M systems responsible for m5C modification, and (iv) four Type IIG R/M systems responsible for m6A modification (Figure [4](#F4){ref-type="fig"}; Tables [3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}).

*In silico* analysis of the distribution of methylated motifs across *B. breve* revealed that adenine modification (m6A) is the preferred methylation activity in R/Ms of this species, occurring in 10 out of 15 RM-COGs identified. Closer inspection of the genetic organization of each R/M system also revealed that members of the RM7-COG and RM8-COG appear to constitute non- or partially functional R/M systems, where methylome analysis was able to detect a methylated motif assignable to a particular MTase-encoding gene, although the corresponding RE-encoding gene appears to be truncated ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}, panels A and B). In the case of members of the RM7-COG we found either complete or truncated R/M systems, depending on the strain analysed ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}, panel B). Interestingly, these apparently partially functioning R/Ms are predicted to be responsible for cytosine modification (m5C) and are present in 15 out of the 21 strains investigated. It is worth mentioning that a recent study based on genome wide insertional mutagenesis in *B. breve* UCC2003 identified M.BbrI of the apparently truncated BbrI R/M system as essential for the survival of this strain, which suggests that this system (a member of the RM8-COG group) is at least partially functional ([@B52]).

Based on the occurrence of each motif across genomes and the type of modification observed (methylation of either both strands or one strand of a given recognition sequence), it is likely that not all of these systems impact equally on the genetic accessibility of strains or horizontal gene transfer in general. For example, the 5′-G^m6^**A**[T]{.ul}C-3′ palindromic recognition motif of the RM3-COG group, which is present in four *B. breve* strains, occurs at a high frequency in DNA and indeed may constitute a strong barrier to horizontal transfer and genetic accessibility. Other systems instead recognize larger, less frequently occurring and sometimes non-palindromic motifs (e.g. members of RM10-, RM13-, RM14- and RM15-COGs) (Figure [4](#F4){ref-type="fig"}).

Of note, our analysis also identified 12 presumed orphan MTases with no associated motif as based on methylome data. A large proportion of these are found within mobile genetic regions in *B. breve* NRBB57 and *B. breve* 215W4--47a, and they may constitute either non-functional or non-expressed methylases of degenerated R/M systems (Table [3](#tbl3){ref-type="table"}).

Type I R/M systems in *B. breve* {#SEC3-5}
--------------------------------

Type I RM systems are commonly present in *B. breve*, as they are observed in nine out of the 20 examined strains (Table [3](#tbl3){ref-type="table"}). Based on sequence similarity of M and R subunits the identified Type I systems are classified into two main phylogenetic groups (corresponding to the RM1- and RM2-COGs assignment as based on comparative genome analysis, see above) (Figure [5](#F5){ref-type="fig"}). Detailed inspection of the Type I R/M-encoding genomic region in individual *B. breve* strains revealed in each of the nine cases the presence of multiple copies of the S-encoding gene, which does not always represent a complete S-subunit (and are located adjacent to single R- and M-encoding genes). Alignment of Type I R/M system-encoding regions extracted from the nine *B. breve* strains showed that these loci differ mainly at the level of the partial/complete *hsdS* genes (Tables [3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}; Figure [5](#F5){ref-type="fig"}). In all cases we observed that these specificity determinants are located adjacent to a gene encoding a putative site-specific recombinase, which may catalyze *hsdS* reshuffling to generate diversity in recognition motifs, a phenomenon that has previously been described ([@B26]).

When comparing the observed Type I R/M systems with the phylogenetic relatedness of *B. breve* strains, it is worth noting that *B. breve* NRBB01 and *B. breve* CNCM I-4321 which exhibit a similar Type I R/M arrangement (Figure [5](#F5){ref-type="fig"}, panel B) also appear to be closely related at phylogenetic level (Figure [2](#F2){ref-type="fig"}).

It is also worth mentioning that (with the exception of *B. breve* NRBB51) the Type I R/M system is encoded within the same genomic region that also harbours a tRNA synthetase-encoding gene, a phenomenon that has previously been observed for other bacteria ([@B53],[@B54]). Interestingly, of the nine identified motifs associated with *B. breve* Type I RMs, 7 represent novel motifs (<http://rebase.neb.com/rebase/rebase.html>), suggesting that *hsdS* reshuffling causes a high level of recognition motif diversity and dynamics.

Type II and IIG R/M systems in *B. breve* {#SEC3-6}
-----------------------------------------

Type II R/M-associated motifs (also including the Type IIG subgroup, in which MTase and REase activities are encoded by a single gene) are diverse in *B. breve* (13 out of the 22 identified motifs) (Table [3](#tbl3){ref-type="table"}). Interestingly, nine of the 13 identified Type II R/Ms in *B. breve* are presumed to recognize palindromic sequences (Figure [4](#F4){ref-type="fig"}). The remaining four Type II R/Ms are deduced to recognize an asymmetric motif (which, when methylated result in single strand methylation within that recognition sequence). Interestingly, the genes encoding these four Type II R/M systems are located within putative mobile genetic elements, indicative of horizontal acquisition.

Notably, among the 13 identified Type II R/M systems M.Bbr11ORF942P is associated with a novel motif (according to <http://rebase.neb.com/rebase/rebase.html>; ([@B21])). Furthermore, we observed similarity between Type II M.Bbr11ORF942P and Type IIG Bbr57III, where the individual MTase display ∼50% similarity with the first half of Bbr57III ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}), suggesting its origin from a fusion between MTase- and RE-encoding genes of a Type II system.

Genomic DNA digestion with commercially available enzymes {#SEC3-7}
---------------------------------------------------------

It was reasoned that the deduced methylated recognition sequences of these genomes provides protection against restriction enzymes that target such sequences (if they are sensitive to the corresponding methylation position). In order to verify this presumption, genomic DNA from a number of selected strains (*B. breve* NRBB01, *B. breve* NRBB02, *B. breve* NRBB57, *B. breve* NRBB04, *B. breve* 180W8--3 and *B. breve* NRBB52) was treated with selected restriction enzymes and analysed by agarose gel electrophoresis. Restriction of *B. breve* NRBB01 gDNA with DpnII, MscI or BamHI (control) demonstrated that NRBB01, NRBB02 and NRBB04 gDNA is protected from restriction by DpnII. This shows that, as expected from the methylome analysis, homologs of the predicted MTase M.Bbr01I member of the RM3-COG (Tables [3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}) are responsible for methylation at a 5′-G^m6^**A**[T]{.ul}C-3′ recognition sequence ([Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). Digestion of *B. breve* NRBB02 genomic DNA with EheI confirmed that homologs of M.Bbr02II members of the RM8-COG (Tables [3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}) are responsible for the methylation of 5′-GG ^m5^**C**[G]{.ul}CC-3′ sites ([Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). Indeed, the M.Bbr02II homolog in *B. breve* UCC2003 (constituting an R/M named BbrI), has previously been described to recognize a 5′-GG^m5^**C**[G]{.ul}CC-3′ motif ([@B19]). Restriction of *B. breve* NRBB57 gDNA with EcoRII or BamHI (the latter being a positive control) demonstrated that *B. breve* NRBB57 gDNA is protected by the methylation activity provided by M.Bbr57ORF730P of RM6-COG (Tables [3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}; [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). Furthermore, restriction analysis of *B. breve* 180W8--3 gDNA with EcoRI, EcoRII or EheI demonstrated that gDNA of this strain is cleaved by EcoRI, but protected from restriction by EcoRII or EheI. This suggests that M.Bbr180I of RM7-COG in *B. breve* 180W8--3 is responsible for methylation at 5′-C ^m5^**C**W[G]{.ul}G-3′ sites, while M.Bbr180II of RM8-COG is responsible for methylation of 5′-GG ^m5^**C**[G]{.ul}CC-3′ recognition sequences ([Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). Finally, restriction of *B. breve* NRBB52 gDNA with DpnII, PsuI and EcoRI (control) showed that gDNA of this strain is not protected from restriction with any of the enzymes tested ([Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). As expected, M.Bbr52I which together with its homologs form RM4-COG, methylates 5′-RG^m6^**A**[T]{.ul}CY-3′ sites (Tables [3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}), does not provide (full) protection against DpnII or PsuI digestion.

Methylase cloning and evaluation of genetic accessibility of *B. breve* strains {#SEC3-8}
-------------------------------------------------------------------------------

In order to obtain information on the genetic accessibility of *B. breve* strains, a set of seven plasmids (Table [1](#tbl1){ref-type="table"}) was tested across a panel of six sequenced *B. breve* representatives in order to determine their transformation efficiencies (Table [5](#tbl5){ref-type="table"}). As from the obtained results the transformation efficiencies were shown to be extremely variable across *B. breve* strains and plasmids, suggesting that certain strains impose barriers, such as R/M systems, that limit the introduction of foreign DNA (Table [5](#tbl5){ref-type="table"}).

###### Evaluation of genetic accessibility of *B. breve* strains with different plasmids (expressed as average of duplicate attempts) and impact of R/M systems. Results are expressed in CFUs/microgram of plasmid DNA

  *B. breve* strain   *E. coli* strain         *E. coli* plasmid DNA   *B. breve* plasmid DNA   *E. coli* ER2796 (pNZ-M.Bbr52I) plasmid DNA   Plasmid            Active R/Ms
  ------------------- ------------------------ ----------------------- ------------------------ --------------------------------------------- ------------------ -------------
  **DRBB27**          **ER2796 (Dam-)**        5.95 × 10^4^            6.0 × 10^4^              \-                                            **pNZ8048 (Cm)**   No
  **NRBB50**          **ER2796 (Dam-)**        5.4 × 10^4^             4.85 × 10^4^             \-                                            **pAM5 (Tet)**     Partial R/M
  **NRBB01**          **EC101 (Dam+)**         8.8 × 10^3^             1.4 × 10^5^              \-                                            **pNZ8048 (Cm)**   Yes
  **NRBB02**          **EC101 (Dam+)**         2.01 × 10^5^            2.8 × 10^5^              \-                                            **pAM5 (Tet)**     Yes
  **NRBB02**          **ER2796 (Dam-)**        No transformants        \-                       \-                                            **pAM5 (Tet)**     Yes
  **NRBB57**          **EC101 (Dam+)**         5.37 × 10^4^            1.03 × 10^6^             \-                                            **pDM1 (Spec)**    Yes
  **NRBB52**          **C29251 (Dam-/Dcm-)**   3.53 × 10^2^            7.05 × 10^5^             1.37 × 10^6^                                  **pAM5 (Tet)**     Yes

In order to determine the impact of R/M systems on genetic accessibility, six *B. breve* representatives were examined (*B. breve* NRBB01, *B. breve* NRBB02, *B. breve* NRBB57, *B. breve* DRBB27, *B. breve* NRBB50 and *B. breve* NRBB52). For this purpose *B. breve* strains were first transformed with plasmids isolated from *E. coli* and the obtained bifidobacterial transformants were then used to recover these same plasmids, which would now be assumed to be methylated by native R/M systems. Interestingly and in line with our expectations, subsequent reintroduction of such methylated plasmid DNA into the same *B. breve* strains was shown to result in an increased transformation efficiency for those strains harbouring (functional) R/M systems. In contrast, the transformation efficacy of strains that did not encode, or were predicted to encode non-functional R/M systems was not increased when such methylated plasmid DNA was employed (Table [5](#tbl5){ref-type="table"}). In particular, the absence of active R/M systems in *B. breve* DRBB27 and *B. breve* NRBB50 correlated with a high transformation efficiency of these strains.

A first indication that methylome information can be employed to circumvent the R/M barrier to make *B. breve* strains genetically more accessible was obtained by *B. breve* strain NRBB02 which harbours an active Bbr02I R/M system with a GATC-specific restriction endonuclease. For this strain no transformants were obtained when pAM5-tet plasmid DNA (containing twenty eight 5′-GATC-3′ sites) isolated from *E. coli* ER2796 (DAM^--^ strain that does not methylate 5′-G^m6^**A**[T]{.ul}C-3′ sites) was used to transform this strain. Results from the transformation experiments show that M.Bbr02I is extremely active against 5′-GATC-3′ sites because a high transformation efficiency was obtained when plasmid DNA was used to transform *B. breve* NRBB02 that had been isolated from *E. coli* EC101 (DAM+ strain) (Table [5](#tbl5){ref-type="table"}). This result confirms that a 5′-GATC-3′ targeting R/M system imposes a significant barrier to DNA acquisition.

In order to further substantiate our findings and to improve the genetic accessibility of this species, *B. breve* NRBB52 was selected as a target strain, based on the fact that it harbours a Type II R/M system (Bbr52I), which recognizes the relatively frequently occurring 5′-RGATCY-3′ sequence motif, and which thus is expected to imposes a substantial barrier to transformation. The M.Bbr52I methylase gene was cloned into pNZ8048 and introduced into *E. coli* ER2796 strain (see M&M), to generate strain *E. coli* ER2796.pNZ-M.NBB52. When the methylated pAM5 shuttle vector isolated from *E. coli* ER2796.pNZ-M.NBB52 harbouring the M.Bbr52I cloned MTase was used to transform *B. breve* NRBB52, a 4000-fold increase in the transformation efficiency was observed compared to the unmethylated pAM5 DNA from *E. coli* C29251 (Table [5](#tbl5){ref-type="table"}). These results are not only consistent with the presence of an active Bbr52I system in *B. breve* NRBB52, but also confirm that the deduced methylome in this study can be succesfully used to improve the genetic accessibility of a given *B. breve* strain.

R/M systems and horizontal transfer in *B. breve* {#SEC3-9}
-------------------------------------------------

R/M and CRISPR-Cas systems are believed to constitute the main barriers to horizontal transfer (HGT) in bacteria ([@B16]). To investigate this presumed barrier function, we searched (using PFAM and visual inspection) the 19 newly sequenced *B. breve* genomes for the presence of large chromosome-associated mobile regions in the form of prophages, integrated episomes and genomic regions (\>20 kb) that contain a high density of hypothetical proteins and transposases possibly constituting a remnant of an acquired mobile genetic element. The analysis revealed the presence of such elements across *B. breve* ranging between a minimum of 1 to a maximum of 5 elements per genome. Interestingly, we found conserved prophages and Integrative Conjugative Elements (ICEs) always integrated in putative tRNA genes located in conserved positions along the chromosome, indicating the existence of integration hot spots in *B. breve* (Figure [6](#F6){ref-type="fig"}, panel A). Furthermore, it also appears that the occurrence and integration of these elements is more frequent around the Ter region of the *B. breve* chromosome (Figure [6](#F6){ref-type="fig"}, panel A).

![The *B. breve* mobilome and the impact of HGT on bacterial genome size. (**A**) Schematic representation of 20 *B. breve* strains and their predicted mobile genetic elements with genome size. Strains are divided in two groups based on the genome length and size of the cumulative mobilome. (**B**) Barplot showing differential distribution of mobilome DNA in the two size groups (orange and blue), ordered by genome length.](gkx1289fig6){#F6}

In order to determine if *B. breve* CRISPR-Cas and R/M systems impact on the frequency of (predicted) HGT, we searched for correlations between the presence/absence of such systems and the number of identified mobile genetic elements. Interestingly, 12 out of the 20 examined strains (19 *B. breve* representatives here sequenced plus the reference strain *B. breve* UCC2003) lack a CRISPR-Cas system, perhaps lowering the barrier to acquire exogenous genetic material (Table [2](#tbl2){ref-type="table"}). In addition, our analysis revealed a correlation between the absence of CRISPR or short-target R/Ms (e.g. 5′-G^m6^**A**[T]{.ul}C-3′ associated with the RM3 cluster), and an increase of accessory gene families (variome) within the species, which possibly reflects the impact of the former systems on DNA acquisition by horizontal transfer means in *B. breve* (Figure [7](#F7){ref-type="fig"}, panel B).

![Horizontal Gene Transfer in *B. breve* strains. (**A**) Presence/absence of detected motifs in genomes ordered by frequency of occurrence. *B. breve* strains are grouped into two distinct clusters based on the genome length and the contribution of presence of CRISPR and R/M on HGT. Discriminant of the two groups at 2.4 Mb is also indicated. (**B**) Boxplot showing the inverse correlation between the presence of CRISPR and/or short-target R/M systems and variome size (expressed as number of accessory gene families \[GF\] in genomes). Median of each group and exact *P*-value are also indicated. Hypothesis tested with the Mann--Withney U test (significance *P* \< 0.05).](gkx1289fig7){#F7}

In contrast, when neither a CRISPR locus nor a 5′-G^m6^**A**[T]{.ul}C-3′-targeting R/M system is present in a given *B. breve* strain, we observed a higher number of integrated mobile genetic elements in the corresponding genome. For example, the *B. breve* NRBB57 and *B. breve* 215W4-47a genomes contain three and five acquired regions, respectively, of which one is an ICE of ∼200 kb. The same can be said for *B. breve* CNCM I-4321 containing the highest number (five) of large mobile genetic elements so far observed in *B. breve* integrated in the chromosome (two prophages and three ICSs), accounting for a total of ∼300 kb of putatively acquired DNA (Figure [6](#F6){ref-type="fig"}).

CONCLUSIONS {#SEC4}
===========

The present study demonstrates the successful application of PacBio SMRT RSII sequencing to a large *B. breve* collection for the purpose of methylome analysis, in selected cases supplemented with BS-seq analysis and MTase cloning. These efforts generated a comprehensive overview of the R/M systems present in this bifidobacterial species.

The methylome definition of *B. breve* strains showed a high prevalence of m6A and m5C methylation across strains, while m4C methylation appears to be a rare occurrence. Accurate inspection of the methylation context of each modification allowed the identification of 15 distinct R/M systems assignable to Type I and Type II/IIG systems. As the occurrence of their recognized motifs also appears to be quite variable, it follows that they variably affect genetic accessibility of strains or horizontal gene transfer in general.

Among the various differences observed across the genomes analyzed, the considerable variability in genome size of strains was a rather striking feature. Moreover, the occurrence of additional DNA was limited to certain chromosomal locations (in particular the Ter region) and allowed the identification of tRNA genes as possible hot-spots for insertion of not only prophages, but also mobile genetic elements in general.

The frequent presence of mobile elements in those genomes lacking a CRISPR locus and/or R/M systems also suggests considerable impact of bacterial defense mechanisms on acquisition of exogenous DNA in *B. breve* and bifidobacteria in general (with possible advantages for the host which still needs to be further elucidated).

In conclusion, the present work demonstrates that representatives of *B. breve* exhibit considerable genomic diversity data, though such diversity seems to be balanced by the need of the host to protect itself against genetic invasions. The large diversity of defence systems, in particular R/M systems, may pose a substantial barrier to studies that want to investigate the genetic traits associated with these gut commensals, in particular if such traits are considered beneficial to its host. The findings of our methylome analysis coupled with the most complete identification of R/M systems in *B. breve*, represents an important advance in making bifidobacteria more genetically accessible. Ultimately, this will result in an improved understanding of the genetics and health-promoting potential of members of this species.
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